FOLLOWUS
Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine
Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine
- 中国结合医学杂志（英文版） 2018年24卷第8期 页码：632-640
- Affiliations：
1. Graduate School, Beijing University of Chinese Medicine,Beijing,China
2. Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
3. China Heart Institute of Chinese Medicine, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：Supported by the National Natural Science Foundation of China (No. 81030063 and No. 81202837)
DOI：10.1007/s11655-015-2297-9
中图分类号：纸质出版日期：2018，
网络出版日期：2015-10-10，
Scan for full text
Zhang, Y., Ma, Xj. & Shi, Dz. Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine., Chin. J. Integr. Med. 24, 632–640 (2018). https://doi.org/10.1007/s11655-015-2297-9
Ying Zhang, Xiao-juan Ma, Da-zhuo Shi. Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine[J]. Chinese Journal of Integrative Medicine, 2018,24(8):632-640.
Zhang, Y., Ma, Xj. & Shi, Dz. Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine., Chin. J. Integr. Med. 24, 632–640 (2018). https://doi.org/10.1007/s11655-015-2297-9 DOI：
Ying Zhang, Xiao-juan Ma, Da-zhuo Shi. Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine[J]. Chinese Journal of Integrative Medicine, 2018,24(8):632-640. DOI： 10.1007/s11655-015-2297-9.
摘要
Atherothrombosis is the major cause of acute coronary syndromes and cardiovascular deaths. Platelets participate in the processes of forming and extending atherosclerotic plaques. Therefore
antiplatelet therapy is a milestone in the primary and second prevention of atherothrombotic diseases. Along with the longterm use of antiplatelet agents
the safety and drug resistance has become a big concern in clinic and new drugs possessing higher effectiveness and fewer adverse effects are needed. Abundant recent data support that traditional Chinese herbs may be a good alternative and complementary choice of new antiplatelet drugs. This review highlights the progress of antiplatelet effect of active components derived from traditional Chinese herbs based on their chemical structures.
Abstract
Atherothrombosis is the major cause of acute coronary syndromes and cardiovascular deaths. Platelets participate in the processes of forming and extending atherosclerotic plaques. Therefore
antiplatelet therapy is a milestone in the primary and second prevention of atherothrombotic diseases. Along with the longterm use of antiplatelet agents
the safety and drug resistance has become a big concern in clinic and new drugs possessing higher effectiveness and fewer adverse effects are needed. Abundant recent data support that traditional Chinese herbs may be a good alternative and complementary choice of new antiplatelet drugs. This review highlights the progress of antiplatelet effect of active components derived from traditional Chinese herbs based on their chemical structures.
关键词
Chinese Herbal Medicineantiplateletactive components
Keywords
Chinese Herbal Medicineantiplateletactive components
references
Trenk D, Nührenberg T, Stratz C, Valina CM, Hochholzer W. Clinical pharmacology of current antiplatelet drugs. Cardiovascul Dis (Germ) 2014;39:790–797.
Bueno H, Pocock S, Danchin N, Annemans L, Medina J, Millegard M, et al. EPICOR: an international study of the duration of dual antiplatelet therapy in survivors of acute coronary syndromes. Circulation 2014;130:A16705–A16705.
Tang XF, Fan JY, Meng J, Jin C, Yuan JQ, Yang YJ. Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials. Atherosclerosis 2014;233:568–578.
Tantry US, Gesheff M, Liu F, Bliden KP, Gurbel PA. Resistance to antiplatelet drugs: what progress has been made? Expert Opin Pharmacother 2014;15:2553–2564.
Yao H, Zhang JP, Chen ZX, Li ZQ. Effects of Buyang Huanwu Decoction and Astragalus Mongholicus on PAF receptor activity in rabbits in vitro. J Tradit Chin Med (Chin) 2006;17:613–615.
Wang J, Xiong XJ, Feng B. Aspirin resistance and promoting blood circulation and removing blood stasis: current situation and prospectives. Evid Based Complement Alternat Med 2014;2014:954863.
Xu L, Huang Y. Effects of Bai Yu Ginkgolide Injection on platelet aggregation in rabbits. J Emerg Tradit Chin Med (Chin) 2014;23:638–639.
Liu XQ, Yan Y, Bao L, Chen BD, Zhao YY, Qi RM. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. Thromb Res 2014;134:1066–1073.
Xu XY. Effect of tanshinone II A on autoimmune vasculitis, platelets and clotting activity. Chin J Gerontol (Chin) 2013;33:4201–4203.
Maione F, De FV, Caiazzo E, De Martino L, Cicala C, Mascolo N. Tanshinone II A, a major component of Salvia milthorriza Bunge, inhibits platelet activation via ERK-2 signaling pathway. J Ethnopharmacol 2014;155:1236–1242.
Xia Q, Dong TX, Zhan HQ, Liang JR, Li SP. Inhibition effect of curdione on platelet aggregation induced by ADP in rabbits. Chin Pharmaco Bull (Chin) 2006;22:1151–1152.
Xia Q, Wang X, Xu DJ, Chen XH, Chen FH. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential oil. Thromb Res 2012;130:409–414.
Liu C, Wang J, Yang J. Study on activating blood and eliminating stasis of total paeony glycoside. J Chin Med Mater (Chin) 2000;23:557–560.
Lau AJ, Toh DF, Chua TK, Pang YK, Woo SO, Koh HL. Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. J Ethnopharmacol 2009;125:380–386.
Chen JB, Sun XM, Fang YY. Effects of Panaxnotoginseng on endothelin-1 and blood platelet function in patients with angina pectoris of coronary heart disease. Chin J Integr Tradit West Med Intens Crit Care (Chin) 2009;16:96–97.
Nie DN, Zeng FR, Xie SF, Li YQ, Ma LP, Wu YD, et al. A study of effects of ginsengoside-2A on platelet function in hypertention patients. New Chin Med (Chin) 2004;35:20–21.
Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Gins Res 2014;38:161–166.
Wang F, Zhou YB. Progress of pharmacological studies of ginsenosides-Rb3. Acta Chin Med Pharmaco (Chin) 2012;40:93–94.
Zhou Q, Jiang L, Xu CX, Luo DJ, Zeng CL, Liu P, et al. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb Res 2014;133:57–65.
Xu XX, Xia LZ, Gao JR, Liu QY, Peng DY. Synergistic antiplatelet effect of total paeony glycoside and total saponins of astragalus. J Chin Med Mater (Chin) 2002;25:653–654.
Ma HY, Zhou QL, Wang BX. Antagonistic effect of DX and diosgenin on hyperlipidemia induced by cholesterol in vivo and on blood platelet aggregation in vitro. Chin J Hosp Pharm (Chin) 2002;22:323–325.
Yin HJ, Zhou DY, Jiang YY, Luo L, Shi DZ. Effect of total saponins of tribulus on platelet activation and carotid arterial thrombosis in hyperlidemia rats. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2005;3:138–140.
Yu CD, Chen ZL, Mei QX. Overview of the pharmacological effects of gynostemma. Lishizhen Med Mater Mecida Res (Chin) 2008;19:9–10.
Cong Y. Study on the molecular mechanism of anti-platelet activity of steroid saponins from Anemarrhenaeasphodeloides Bge. Acad Mil Med Sci (Chin) 2010.
Kang LP, Zhang J, Cong Y, Li B, Xiong CQ, Zhao Y, et al. Steroidal glycosides from the rhizomes of Anemarrhenaasphodeloides and their antiplatelet aggregation activity. Planta Med 2012;78:611–616.
Wei M, Zhou HB. Active components and pharmacological effects of soybean. Acad J Guangdong Coll Pharm (Chin) 2001;17:21.
Yu DH, Mao SL. Effects of acanthopanax senticosus saponins on platelet, blood coagulation and blood viscosity in rabbits. J Pharmaceut Pract (Chin) 2008;26:272–274.
Kozlowska A, Szostak-Wegierek D. Flavonoids-food sources and health benefits. Ann Nat Jnstit Hygiene 2014;65:79–85.
Pan SH., Lin DP. Effect of isoginkgetin on rabbit platelet aggregation and fibrinogen content. J Anhui Tradi Chin Med Coll (Chin) 1994;13:59–60.
Zang BX, Wu W, Chen HY, Dong NN, Jin M, Tong J. Inhibitory effect of safflower yellow on rabbit platelet aggregation induced by ADP and the protective effect on myocyte oxygen and glucose deprivation. J Cardiovasc Pulm Dis (Chin) 2012;31:736–739.
Deng ZY, Zhu SM, Wang D, Kang H, Kuang R. Effects of puerarin on lipidemia, blood coagulation and platelet aggregation in hyperlipidemia rats. Chin J Mod Appl Pharm (Chin) 2011;28:611–614.
Luo ZR, Zheng B. Effect of Puerarin on platelet activating factors CD63 and CD62P, plasminogen activator inhibitor and C-reactive protein in patients with unstable angian pectoris. Chin J Integr Tradit West Med (Chin) 2001;21:31–33.
Song Y, Zhang HM, Ma JJ, Li CL. Effects of scutellarein on thrombosis and hemorheology in rats. Chin J New Drugs (Chin) 2011;20:1446–1449.
Gao ZXZ, Huang DY, Li HX, Zhang LN, Lv YH, Cui HD, et al. Scutellarein promotes in vitro angiogenesis in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2010;400:151–156.
Lee JJ, Yang H, Yoo YM, Hong SS, Lee D, Lee HJ, et al. Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease. J Atheroscler Thromb 2012;19:516–522.
Yi T, Chen HB, Zhao ZZ, Yu ZL, Jiang ZH. Comparison of the chemical profiles and anti-platelet aggregation effects of two “dragon’s blood” drugs used in traditional Chinese medicine. J Ethnopharmacol 2011;133:796–802.
Jia M, Chen J. Anti-thrombotic effect of flavones in Resina Draconis and its potential mechanisms. Chin Pharm Aff (Chin) 2013;27:876–878.
Xiao Y, Li LL, Wang YY, Guo JJ, Xu WP, Wang YY, et al. Naringin administration inhibits platelet aggregation and release by reducing blood cholesterol levels and the cytosolic free calcium concentration in hyperlipidemic rabbits. Exp Ther Med 2014 8:968–972.
Lu TL, Ye DJ, Mao CQ, Liu XS. Studies on antiplatelet aggregation and antithrombosis action of total flavonoids of Common Burreed. Chin Tradit Herb Drugs (Chin) 1999;30:439–440.
Ao Y, Liu WW, Yan CK, Tu ZB, Mi LX, Wang HY. Effects of FMG on the activity of platelet aggregation, release and its ultrastructure in typercholesteremic rats. Chin J Hosp Pharm (Chin) 2004;24:657–659.
Tsai WJ, Hsin WC, Chen CC. Antiplatelet flavonoids from seeds of Psoralea corylifolia. J Nat Prod 1996;59:671–672.
Yang R, Wei WN, Wang AL, Liu ZP, Shen Di. Explore of TMPZ on platelet aggregation inhibition and depolymerization of three activation pathways. Chin J Hemorheol (Chin) 1995;5:4–7.
Sheu JR, Kan YC, Hung WC, Lin CH, Yen MH. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NOsynthase. Life Sci 2000;67:937–947.
Wang WT, Lin LN, Xu ZX. Effects of ligustrazine on the platelet aggregation of heart valve replacement patients. Chin J Integr Tradit West Med (Chin) 2000;20:25.
Chu ZL, Jiang YF, Wang ZH, Song CQ, Xu ZP. Effects of berberine on platelet aggregation and release. Acad J Second Mill Med Univ (Chin) 1989;10:323–327.
Yue F, Gao Y. Effect of sodium ferulate on platelet activition and blood rheology in type-2 diabetes. J Taishan Med Coll (Chin) 2011;32:609–611.
Yu C, Qi D, Lian W, Li QZ, Li HJ, Fan HY. Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats. PLoS One 2014;9:e0110124.
Guo D, Liu Z, Zhang EH. Research on the platelet inhibition interactions between Tanshinone II A, Danshensu, TMPZ and ferulic acid. Shaanxi J Tradit Chin Med (Chin) 2007;28:743–745.
Liu L, Li J, Zhang Y, Zhang S, Ye J, Wen Z, et al. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory. Thromb Res 2014;134 866–876.
Fan HW, Xiao DW, Yu L Zhu Q. The in vitro antiplatelet aggregative effects of Honeysuckle and its organic acid compounds. Chin J Hosp Pharm (Chin) 2006:26:145–147.
Fuentes E, Caballero J, Alarcón M, Rojas A, Palomo I. Chlorogenic acid inhibits human platelet activation and thrombus formation. PLoS One 2014:9:e90699.
Jin YH, Chen YY. Inhibitory effect of Xanthoxylin on blood platelet aggregation in rabbits. Tradit Chin Drug Res Clin Pharmacol (Chin) 2000;11:352–354.
Huang JQ, Luo XX, Wang SW, Xie YH, Shi XY. Effect of cinnamaldehyde on platelet aggregation and thrombosis formation. Chin J Clin Rehabil (Chin) 2006;10:34–36.
Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, et al. Characterization of a platelet-activating factor receptor antagonist, Kadsurenone: specific inhibition of platelet-activating factor in vitro and in vivo. Proc Natl Acad Sci 1985;82:672–676.
Chen R, Xie ML, Zhou J. Experimental study of osthole on inhibition of thrombosis and platelet aggregation. Chin Pharmacol Bull (Chin) 2005:21:440–443.
Huang CG, Li YM, He X, Wei SJ, Jiang H. Effect of angroside in Scrophularia ningpoensis on synthesis of platelet cAMP and plasma PGI2/TXA2 in rabbits. Acad J Second Mil Med Univ (Chin) 2004;25:920–921.
Pan HM, Fang HH, Yan SH. Effects of total flavones from Bidens Bipinnata L. on platelet aggregation in vitro. Her Med (Chin) 2011;30:1273–1274.
Han GM, Yao Q, Li HL. Inhibitory effect of panicoin on platelet activation and its mechanism. Chin J Integr Tradit West Med (Chin) 2000;20:527–529.
Chen Y, Tian Z, Ge YQ, Cai TY. The therapeutic effect of ginger oleoresins on hyperlipidemia and platelet aggregation. Acta Nutrimenta Sinica (Chin) 2001;23:338–340.
Shen CX, Liang C, Xu CF, Chen LL, Qian JY, Wang KQ, et al. The protective effect of a new thrombin inhibitor on the coronary microthrombosis induced by Sodilum Laurate. J Chin Microcircul (Chin) 2003;7:352–356.
Shi HZ, Gao NN, Li YZ, Yu JG, Fan QC, Bai GE. Effects of active fractions from Lycopus Lucidus L. F04 on platelet aggregation and thrombus formation. Space Med Med Eng 2004;17:313–317.
Wong AT. Platelet biology: the role of shear. Expert Rev Hematol. 2013;6:205–212.
Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004;110:e489–e493.
Tomita A, Tamura N, Nanazawa Y, Shiozaki S, Goto S. Development of virtual platelets implementing the functions of three platelet membrane proteins with different adhesive characteristics. J Atheroscler Thromb 2015;22:201–210.
Moore SF, Hunter RW, Hers I. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. J Thromb Haemost 2014;12:748–760.
Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199–202.
Sage SO, Pugh N, Farndale RW, Harper AG. Pericellular Ca2+ recycling potentiates thrombin-evoked Ca2+ signals in human platelets. Physiol Rep 2013;1:e00085.
Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb Res 1997;88:259–270.
Li YH, Liu CH, Zhang YQ, Mi SQ, Wang NS. Pharmacokinetics of ferulic acid and potential interactions with Honghua and clopidogrel in rats. J Ethnopharmacol 2011;137:562–567.
Lin Q, Li XF, Li WJ, Dai R, He XS. Antiaggregation effects of fractions from Gastrodia Rhizome. J Chin Microcircul (Chin) 2006;10:33–34.
Meng BH, Li WJ, Yu ZP, Dai R, Li XF, He XS, et al. Effects of gastrodine on rabbit platelets aggregation in vitro. Pharmacol Clin Chin Mater Med (Chin) 2006;22:46–47.
Zhang AL, Xu QP, Sun JN, Wu Y. Experimental study on the effects of compound Gingko Guttate Pills against thrombosis and platelet aggregation. J Beijing Univ Tradit Chin Med (Chin) 2004;27:42–44.
Wang Y, Wang J, Guo LP, Gao X. Antiplatelet effects of Qishen Yiqi Dropping Pill in platelets aggregation in hyperlipidemic rabbits. Evid Based Complement Alternat Med 2012;2012:205451.
Yuan J, Li XJ, Chen C, Song XG, Wang SM. Predicting effective components and potential targets of Ginkgo biloba on cardio-cerebral vascular diseases based on network pharmacology. Chin J Exp Tradit Med Form (Chin) 2014;20:208–211.
Lee JJ, Kim T, Cho WK, Ma JY. Antithrombotic and antiplatelet activities of Soshiho-tang extract. BMC Complement Altern Med 2013;13:1–8.
Zhu M, Tang Y, Duan JA, Guo J, Guo S, Su S, et al. Roles of paeoniflorin and senkyunolide I in Siwu Decoction on antiplatelet and anticoagulation activities. J Sep Sci 2010;33:3335–3340.
Liu Y, Yin HJ, Shi DZ, Chen KJ. Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies. Evid Based Complement Alternat Med 2012;2012:184503.
0
浏览量
0
Downloads
2
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
